Trade Summary

1 month ago, Ra Capital Management, L.P., serving as Dir, 10% owner at Wave Life Sciences Ltd. (WVE), purchased 8,772,496 shares at $6.23 per share, for a total transaction value of $54,624,378.00. Following this transaction, Ra Capital Management, L.P. now holds 27,004,320 shares of WVE.

This purchase represents a 48.00% increase in Ra Capital Management, L.P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, March 26, 2026 and publicly disclosed via SEC Form 4 filing on Monday, March 30, 2026, 4 days after the trade was made.

Wave Life Sciences Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.